Navigation Links
HIV Drugs Might Combat Two Other Diseases

Prostate cancer, chronic fatique are new research targets

THURSDAY, April 1 (HealthDay News) -- Four anti-HIV drugs inhibit a retrovirus recently linked to prostate cancer and chronic fatigue syndrome (CFS), say U.S. researchers.

If further investigation proves that the retrovirus xenotropic murine leukemia virus-related virus (XMRV) causes prostate cancer or CFS, these HIV drugs may be an effective treatment for the two conditions.

In this study, researchers from the University of Utah and Emory University/Veterans Affair Medical Center tested how effectively 45 compounds used to treat HIV and other viral infections worked against XMRV. Raltegravir was the most effective, and three other drugs -- L-00870812, zidovudine (ZDV or AZT), and tenofovir disoproxil fumarate (TDF) -- also prevented XMRV replication.

"Our study showed that these drugs inhibited XMRV at lower concentrations when two of them were used together, suggesting that possible highly potent 'cocktail' therapies might inhibit the virus from replicating and spreading," Raymond F. Schinazi, a professor of pediatrics and chemistry and an investigator with the Center for AIDS Research at the Emory University School of Medicine and the Atlanta VA, said in a news release.

"This combination of therapies might also have the added benefit of delaying or even preventing the virus from mutating into forms that are drug-resistant," Schinazi added.

"These results offer hope to infected persons, but we are still at the early stages of our understanding of the potential link between XMRV and these diseases," Dr. Ila R. Singh, an associate professor of pathology at the University of Utah Medical School, said in the news release.

The study was published April 1 in the journal PLoS One.

More information

The U.S. Centers for Disease Control and Prevention outlines the possible causes of chronic fatigue syndrome.

-- Robert Preidt

SOURCE: University of Utah Health Sciences, news release, April 1, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Drugs, New Combinations Fight Breast Cancer
2. NICE guidelines ration affordable osteoporosis drugs
3. Bone Drugs May Beat Back Breast Cancer
4. Rehabilitation for Opiate Addiction Without Maintenance Drugs
5. Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
6. Fake Drugs Bought on the Web Pose Big Health Risks
7. Scientists show how molecular switch helps pancreatic cancer beat drugs
8. Common antidepressant drugs linked to lactation difficulties in moms
9. Counterfeit Internet drugs pose significant risks and discourage vital health checks
10. Fertility drugs contribute heavily to multiple births
11. Scientists show how brain tumors outsmart drugs
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... Dr. Thomas ... Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph ... that both STEMI and Sepsis conditions present in similar ways and require time-critical intervention ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the first ... annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the International ... November 11th, 2015. The conference was held at the Hawaii Convention Center in ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a ... ™ attracts volunteers together who want to combine talents and resources to help ... in the process. The non-profit launched its first major fundraiser on November 6, ...
(Date:11/25/2015)... ... ... Dr. John Pierce, Medical Director at the Ageless Forever clinic in Las ... Pro laser therapy cap. FDA cleared for safety and efficacy, the Capillus272 offers men ... surgery, prescription pills, or topical foams. , “Capillus272™ Pro is a home-use device ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... UTRECHT, the Netherlands , November 26, 2015 /PRNewswire/ ...   A new combination approach blends immunotherapy ... --> A new combination approach blends immunotherapy with ... A new combination approach blends immunotherapy with ... the Netherlands has found that immunotherapy ...
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
(Date:11/26/2015)... 26, 2015 ... "2016 Future Horizons and Growth Strategies ... Market: Supplier Shares, Country Segment Forecasts, Competitive ... offering. --> ) has ... Future Horizons and Growth Strategies in the ...
Breaking Medicine Technology: